TREATMENT OF RENAL CARCINOMA USING ANTIBODIES AGAINST THE EGFR

摘要

Methods of treating renal carcinoma are described using fully human monoclon al antibodies ABX-EGF against the epidermal growth factor receptor (EGFr) and antigen binding fragments thereof. Methods of using these renal carcinoma treatments specifically as a monotherapy are also described. In addition, a kit and an article of manufacture for the treatment of renal carcinoma treatment are provided.